- Home
- BDL vs NTRB Comparison
BDL vs NTRB Comparison
Compare BDL & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDL
- NTRB
- Stock Information
- Founded
- BDL 1959
- NTRB 2016
- Country
- BDL United States
- NTRB United States
- Employees
- BDL N/A
- NTRB N/A
- Industry
- BDL Restaurants
- NTRB Industrial Specialties
- Sector
- BDL Consumer Discretionary
- NTRB Health Care
- Exchange
- BDL Nasdaq
- NTRB Nasdaq
- Market Cap
- BDL 48.7M
- NTRB 77.9M
- IPO Year
- BDL N/A
- NTRB N/A
- Fundamental
- Price
- BDL $25.85
- NTRB $7.91
- Analyst Decision
- BDL
- NTRB
- Analyst Count
- BDL 0
- NTRB 0
- Target Price
- BDL N/A
- NTRB N/A
- AVG Volume (30 Days)
- BDL 1.7K
- NTRB 51.9K
- Earning Date
- BDL 08-13-2024
- NTRB 12-11-2024
- Dividend Yield
- BDL 1.92%
- NTRB N/A
- EPS Growth
- BDL N/A
- NTRB N/A
- EPS
- BDL 1.64
- NTRB N/A
- Revenue
- BDL $185,457,000.00
- NTRB $1,803,816.00
- Revenue This Year
- BDL N/A
- NTRB N/A
- Revenue Next Year
- BDL N/A
- NTRB N/A
- P/E Ratio
- BDL $15.87
- NTRB N/A
- Revenue Growth
- BDL 8.71
- NTRB N/A
- 52 Week Low
- BDL $24.43
- NTRB $1.53
- 52 Week High
- BDL $30.79
- NTRB $9.60
- Technical
- Relative Strength Index (RSI)
- BDL 43.55
- NTRB 73.07
- Support Level
- BDL $25.66
- NTRB $6.17
- Resistance Level
- BDL $26.41
- NTRB $7.74
- Average True Range (ATR)
- BDL 0.26
- NTRB 0.58
- MACD
- BDL -0.13
- NTRB 0.16
- Stochastic Oscillator
- BDL 16.72
- NTRB 89.11
About BDL Flanigan's Enterprises Inc.
Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service and Package stores consist of retail liquor sales and related items. The company generates maximum revenue from Restaurant segment.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.